These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 775330)

  • 1. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW; Sherman K; Zwagg RV; Shand DG
    N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
    Bravo EL; Tarazi RC; Dustan HP
    N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of the renin lowering and antihypertensive actions of propranolol.
    Julius S; Esler M; Hansson L; Zwiefler AJ
    Adv Clin Pharmacol; 1976; 11():33-41. PubMed ID: 1032570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol, renin and hypertension: a review.
    Laragh JH; Bühler FR
    Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Propranolol again: order out of chaos?
    Krakoff LR
    N Engl J Med; 1976 Jul; 295(2):102. PubMed ID: 775329
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S82-7. PubMed ID: 2580182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE; Tolagen K
    Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enalapril in the treatment of essential arterial hypertension].
    Pérez-Grovas H; Fernández M; Arriaga J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1986; 56(5):379-90. PubMed ID: 3026264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients.
    Stokes GS; Weber MA; Thornell IR; Stoker LM
    Prog Biochem Pharmacol; 1974; 9():29-44. PubMed ID: 4612559
    [No Abstract]   [Full Text] [Related]  

  • 14. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD; Hesse CJ
    Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.
    O'Malley K; Velasco M; Wells J; McNay JL
    J Clin Invest; 1975 Feb; 55(2):230-5. PubMed ID: 1127099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
    Bühler FR; Lütold BE
    Adv Nephrol Necker Hosp; 1976; 6():303-17. PubMed ID: 14485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose-effect test of Xipamid in hypertension as compared with other antihypertensive drugs].
    Davies PS; Prichard BN
    Med Welt; 1976 Jun; 27(24):1204-8. PubMed ID: 781459
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)].
    Pessina AC; Corgnati A; Palù CD
    G Ital Cardiol; 1976; 6(2):290-9. PubMed ID: 1010180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrochlorothiazide is not additive to verapamil in treating essential hypertension.
    Nicholson JP; Resnick LM; Laragh JH
    Arch Intern Med; 1989 Jan; 149(1):125-8. PubMed ID: 2643413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of increasing doses of DL-propranolol on behavior of arterial pressure and plasma renin activity (PRA)].
    Cerasola G; Morici ML; Amico LM; Biondo S
    Boll Soc Ital Cardiol; 1978; 23(12):2023-34. PubMed ID: 397834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.